These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1702896

  • 1. Non-specific tumoral markers in hepatocellular carcinoma.
    Stanciu L, Dumitraşcu D, Radu D, Badea R.
    Med Interne; 1990; 28(2):139-44. PubMed ID: 1702896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A, Mady EA, Abadeer N, Kamal A.
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
    de Oliveira e Silva A, Roldan-Molina F, dos Santos TE, Santo GC, Miranda MP, Genzini T, Neves LB, D'Albuquerque LA.
    Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.
    J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668
    [Abstract] [Full Text] [Related]

  • 9. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I, Beaudonnet A, Pichot J, Roubille M, Gelineau M.
    Ann Biol Clin (Paris); 2000 Jun 15; 58(1):85-90. PubMed ID: 10673618
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L, Dumitraşcu D, Radu D, Badea R, Petcovici M, Ioniţă A, Szabo P, Pascu O.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988 Jun 15; 40(5):443-9. PubMed ID: 2473509
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF, Peh SC.
    Malays J Pathol; 1991 Dec 15; 13(2):115-8. PubMed ID: 1726642
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.
    Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.